Zacks Investment Research
05 Aug 2026, 18:51 UTC · 2h ago
Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
05 Aug 2026, 18:51 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Waters Corporation reported Q2 2026 adjusted earnings of $3.05 per share and revenues of $1.645 billion, beating consensus estimates for both metrics. — Positive earnings and revenue surprises typically drive short-term stock price appreciation.
+0.40Waters Corporation's revenue surged 113.4% year-over-year, driven significantly by the acquisition of Biosciences and Diagnostic Solutions businesses. — Massive top-line growth validates the company's acquisition strategy and scales the business rapidly.
+0.30Organic revenues rose 9% in constant currency, exceeding the high end of management's guidance by approximately 100 basis points. — Organic growth beating guidance suggests strong underlying demand independent of acquisitions.
+0.30Continue reading
6 related stories
Top 3 movers · tap to explore
Pharma sales climbed 11%, supported by demand from GLP-1, generics, and biologics. — Exposure to high-growth sectors like GLP-1 provides a positive catalyst for long-term valuation.
+0.20The company is currently remediating approximately 700 U.S. Diagnostic Solutions reagent rental contracts identified as out of compliance. — Operational compliance issues represent a minor internal risk and potential drag on immediate efficiency.
-0.10Which stocks this story touches
Company reported adjusted earnings and revenues that both beat consensus estimates, with a significant surge in overall revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
